Trials / Completed
CompletedNCT02568202
Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 449 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study is conducted in the United States of America (USA). Tha aim of this study is bridging Hemophilia B Experiences, Results and Opportunities into Solutions (B-HERO-S).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | This is an online web-based cross-sectional survey in which participants will complete one of two questionnaires. There will be no treatment. |
Timeline
- Start date
- 2015-09-01
- Primary completion
- 2015-11-01
- Completion
- 2015-11-01
- First posted
- 2015-10-05
- Last updated
- 2016-01-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02568202. Inclusion in this directory is not an endorsement.